Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.49 |
| ▸ | GRIN2D | O15399 | 4/20 | 0.47 |
| ▸ | GRIN3B | O60391 | 4/20 | 0.47 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.47 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.47 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.47 |
| ▸ | GRIN2C | Q14957 | 4/20 | 0.47 |
| ▸ | GRIN3A | Q8TCU5 | 4/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | EBP | Q15125 | 1/20 | 0.47 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24133230 | 1.00 | SIGMAR1 (0.49) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL29074603 | 0.83 | TRPA1 (0.45) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL29664063 | 0.83 | MAPT (0.52) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL11295615 | 0.79 | TSHR (0.48) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL11210126 | 0.77 | MAPT (0.43) | TSHRMEN1KMT2AMAPTHTT | |
| SCHEMBL11290782 | 0.77 | KEAP1 (0.42) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL11015269 | 0.77 | MAPT (0.43) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL10519325 | 0.77 | MAPT (0.46) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL13241362 | 0.77 | CYP2C9 (0.44) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL9597558 | 0.77 | CYP2C9 (0.44) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4076940-B1 | A SEALING DEVICE WITH HIGH SURFACE ROUGHNESS | SIKA TECH AG (CH) | 2025-06-04 | — | — | EP | claimed |
| CN-114728494-B | Sealing device with high surface roughness | SIKA技术股份公司 | 2024-12-31 | — | — | CN | claimed |
| US-12163588-B2 | Sealing device with increased surface roughness | SIKA TECHNOLOGY AG (CH) | 2024-12-10 | — | — | US | claimed |
| US-20230399779-A1 | Polymeric Non-Woven Mat | America Plastics, LLC (US) | 2023-12-14 | — | — | US | claimed |
| US-20220396056-A1 | A SEALING DEVICE WITH INCREASED SURFACE ROUGHNESS | SIKA TECHNOLOGY AG (CH) | 2022-12-15 | — | — | US | claimed |
| EP-4076940-A1 | A SEALING DEVICE WITH HIGH SURFACE ROUGHNESS | Sika Technology AG (CH) | 2022-10-26 | — | — | EP | claimed |
| CN-114728494-A | Sealing device with high surface roughness | SIKA技术股份公司 | 2022-07-08 | — | — | CN | claimed |
| US-12552140-B2 | Sealing device with increased concrete adhesion strength | SIKA TECHNOLOGY AG (CH) | 2026-02-17 | — | — | US | disclosed |
| US-12509879-B2 | Fully bonded single-layer waterbar | SIKA TECHNOLOGY AG (CH) | 2025-12-30 | — | — | US | disclosed |
| US-12343964-B2 | Waterproofing membrane with a solid filler component | SIKA TECHNOLOGY AG (CH) | 2025-07-01 | — | — | US | disclosed |
| EP-4168637-B1 | PROCESS FOR PRODUCING A FULLY BONDED SINGLE-LAYER WATERBAR | SIKA TECH AG (CH) | 2025-06-11 | — | — | EP | disclosed |
| EP-4076940-B1 | A SEALING DEVICE WITH HIGH SURFACE ROUGHNESS | SIKA TECH AG (CH) | 2025-06-04 | — | — | EP | disclosed |
| US-20250101265-A1 | THIN FILM SEALING DEVICE WITH IMPROVED ADHESION TO CONCRETE | SIKA TECHNOLOGY AG (CH) | 2025-03-27 | — | — | US | disclosed |
| EP-0013643-B1 | PRODUCTION OF HIGH-QUALITY AROMATIC AMINO AZO COMPOUNDS BY THE REARRANGEMENT OF 1,3-DIARYL TRIAZENES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-12-08 | — | — | EP | disclosed |
| US-4279815-A | DIAZOTIZATION, COUPLING | HERKES FRANK E | 1981-07-21 | — | — | US | disclosed |
| EP-0013643-A1 | Production of high-quality aromatic amino azo compounds by the rearrangement of 1,3-diaryl triazenes | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1980-07-23 | — | — | EP | disclosed |
| US-4089850-A | FOR METAL MODIFIED POLYPROPYLENE | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1978-05-16 | — | — | US | disclosed |
| US-4066388-A | DISAZO DYES DERIVED FROM 1-ACYL-2,4-DIHYDROXYBENZENES AND METALLIZED POLYOLEFIN DYED THEREWITH | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1978-01-03 | — | — | US | disclosed |
| US-4017245-A | Apparatus for extruding expandable thermoplastic material | FOSTER GRANT CO., INC. (US) | 1977-04-12 | — | — | US | disclosed |
| US-4012193-A | Bisazomethine dyes for metal-modified polyolefins | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1977-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509879-B2 | Fully bonded single-layer waterbar | AQP1, GZMB, GJB2 | SIGMAR1 2898/4885GRIN2D 505/4885GRIN3B 1595/4885 |
| US-12552140-B2 | Sealing device with increased concrete adhesion strength | ICAM1, TLN1, CAPZA2 | SIGMAR1 3508/4885GRIN2D 231/4885GRIN3B 3599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.